Deutsche Bank
IBB icon

Deutsche Bank’s iShares Biotechnology ETF IBB Stock Holding History

Deutsche Bank’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-570
Closed -$51K – 6225
2014
Q3 		$51K Buy
+570
New +$50K ﹤0.01% 4845

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Deutsche Bank's IBB Position: Q1 2026 in Review

Deutsche Bank held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 110 shares worth $18.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3535.

Deutsche Bank first reported a position in IBB in Q2 2013 and has held it in 40 quarters since. The position peaked at $467M in Q4 2014. 918 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Deutsche Bank held 110 shares of iShares Biotechnology ETF worth $18.6K as of Q1 2026.
  • Deutsche Bank left its iShares Biotechnology ETF share count unchanged in Q1 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Deutsche Bank's portfolio in Q1 2026, its #3535 holding.
  • Deutsche Bank first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 40 quarters since.
  • Deutsche Bank's iShares Biotechnology ETF position peaked at $467M in Q4 2014.
  • 918 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Deutsche Bank's 13F filing for Q1 2026, filed 6 May 2026.